Quantitative analysis of promoter methylation in exfoliated epithelial cells isolated from breast milk of healthy women

References

• SEER cancer statistics review 1975–2006 2008;
   Google Scholar
• Esserman LJ, Shieh Y, Park JW, Ozanne EM. A role for biomarkers in the screening and diagnosis of breast cancer in younger women. Expert Rev Mol Diagn 2007; 7:533 - 544
   PubMed Web of Science ®Google Scholar
• Buehring GC, Letscher A, McGirr KM, Khandar S, Che LH, Hackett AJ. Presence of epithelial cells in nipple aspirate fluid is associated with subsequent breast cancer: A 25-year prospective study. Breast Cancer Res Treat 2006; 98:63 - 70
   PubMed Web of Science ®Google Scholar
• Fabian CJ, Kimler BF, Mayo MS, Khan SA. Breast-tissue sampling for risk assessment and prevention. Endocr Relat Cancer 2005; 12:185 - 213
   PubMed Web of Science ®Google Scholar
• Arun B. Ductal lavage and risk assessment of breast cancer. Oncologist 2004; 9:599 - 605
   PubMed Web of Science ®Google Scholar
• Tice JA, Miike R, Adduci K, Petrakis NL, King E, Wrensch MR. Nipple aspirate fluid cytology and the gail model for breast cancer risk assessment in a screening population. Cancer Epidemiol Biomarkers Prev 2005; 14:324 - 328
   PubMed Web of Science ®Google Scholar
• Gal-Yam EN, Saito Y, Egger G, Jones PA. Cancer epigenetics: modifications, screening and therapy. Annu Rev Med 2008; 59:267 - 280
   PubMed Web of Science ®Google Scholar
• Esteller M, Corn PG, Baylin SB, Herman JG. A gene hypermethylation profile of human cancer. Cancer Res 2001; 61:3225 - 3229
   PubMed Web of Science ®Google Scholar
• Issa JP. CpG island methylator phenotype in cancer. Nat Rev Cancer 2004; 4:988 - 993
   PubMed Web of Science ®Google Scholar
• Conway KE, McConnell BB, Bowring CE, Donald CD, Warren ST, Vertino PM. TMS1, a novel proapoptotic caspase recruitment domain protein, is a target of methylation-induced gene silencing in human breast cancers. Cancer Res 2000; 60:6236 - 6242
   PubMed Web of Science ®Google Scholar
• Evron E, Dooley WC, Umbricht CB, Rosenthal D, Sacchi N, Gabrielson E, et al. Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR. Lancet 2001; 357:1335 - 1336
   PubMed Web of Science ®Google Scholar
• Jeronimo C, Costa I, Martins MC, Monteiro P, Lisboa S, Palmeira C, et al. Detection of gene promoter hyper-methylation in fine needle washings from breast lesions. Clin Cancer Res 2003; 9:3413 - 3417
   PubMed Web of Science ®Google Scholar
• Yan PS, Shi H, Rahmatpanah F, Hsiau TH, Hsiau AH, Leu Y, et al. Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer. Cancer Res 2003; 63:6178 - 6186
   PubMed Web of Science ®Google Scholar
• Lee JS. GSTP1 promoter hypermethylation is an early event in breast carcinogenesis. Virchows Arch 2007; 450:637 - 642
   PubMed Web of Science ®Google Scholar
• Fackler MJ, Rivers A, Teo WW, Mangat A, Taylor E, Zhang Z, et al. Hypermethylated genes as biomarkers of cancer in women with pathologic nipple discharge. Clin Cancer Res 2009; 15:3802 - 3811
   PubMed Web of Science ®Google Scholar
• Jones P, Baylin S. The epigenomics of cancer. Cell 2007; 128:683 - 692
   PubMed Web of Science ®Google Scholar
• Dworkin A, Huang TH, Toland A. Epigenetic alterations in the breast: implications for breast cancer detection, prognosis and treatment. Semin Cancer Biol 2009; 19:165 - 171
   PubMed Web of Science ®Google Scholar
• Lewis C, Cler L, Bu D, Zchbauer-Mller S, Milchgrub S, Naftalis E, et al. Promoter hypermethylation in benign breast epithelium in relation to predicted breast cancer risk. Clin Cancer Res 2005; 11:166 - 172
   PubMed Web of Science ®Google Scholar
• Euhus DM, Bu D, Milchgrub S, Xie X, Bian A, Leitch AM, et al. DNA methylation in benign breast epithelium in relation to age and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2008; 17:1051 - 1059
   Google Scholar
• Issa JJ, Ahuja N, Toyota M, Bronner MP, Brentnall TA. Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res 2001; 61:3573 - 3577
   PubMed Web of Science ®Google Scholar
• Fraga MF, Esteller M. Epigenetics and aging: the targets and the marks. Trends in Genetics 2007; 23:413 - 418
   PubMed Web of Science ®Google Scholar
• Helewa M, Levesque P, Provencher D, Lea RH, Rosolowich V, Shapiro HM, et al. Breast cancer, pregnancy and breastfeeding. J Obstet Gynaecol Can 2002; 24:164 - 180
   PubMedGoogle Scholar
• Schedin P. Pregnancy-associated breast cancer and metastasis. Nat Rev Cancer 2006; 6:281 - 291
   PubMed Web of Science ®Google Scholar
• Trichopoulos D, Hsieh CC, MacMahon B, Lin TM, Lowe CR, Mirra AP, et al. Age at any birth and breast cancer risk. Internat J Cancer 1983; 31:701 - 704
   PubMed Web of Science ®Google Scholar
• Albrektsen G, Heuch I, Hansen S, Kvle G. Breast cancer risk by age at birth, time since birth and time intervals between births: exploring interaction effects. Brit J Cancer 2005; 92:167 - 175
   PubMed Web of Science ®Google Scholar
• Srinivasula S, Poyet J, Razmara M, Datta P, Zhang Z, Alnemri E. The PYRIN-CARD protein ASC is an activating adaptor for caspase-1. JBC 2002; 277:21119 - 21122
   PubMed Web of Science ®Google Scholar
• Mirza S, Sharma G, Prasad CP, Parshad R, Srivastava A, Gupta SD, et al. Promoter hypermethylation of TMS1, BRCA1, ERα and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients. Life Sci 2007; 81:280 - 287
   PubMed Web of Science ®Google Scholar
• Li S, Rong M, Iacopetta B. DNA hypermethylation in breast cancer and its association with clinicopathological features. Cancer Lett 2006; 237:272 - 280
   PubMed Web of Science ®Google Scholar
• Shinozaki M, Hoon DSB, Giuliano AE, Hansen NM, Wang H, Turner R, et al. Distinct hypermethylation profile of primary breast cancer is associated with sentinel lymph node metastasis. Clin Cancer Res 2005; 11:2156 - 2162
   PubMed Web of Science ®Google Scholar
• Caldeira JRF, Prando E, Quevedo F, Neto FAM, Rainho C, Rogatto S. CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer. BMC Cancer 2006; 6:48 - 57
   PubMed Web of Science ®Google Scholar
• Berx G, Van Roy F. The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression. Breast Can Res 2001; 3:289 - 293
   PubMed Web of Science ®Google Scholar
• Su F, Hu X, Jia W, Gong C, Song E, Hamar P. Glutathione S transferase pi indicates chemotherapy resistance in breast cancer. J Surg Res 2003; 113:102 - 108
   PubMed Web of Science ®Google Scholar
• Zhang YJ, Chen Y, Ahsan H, Lunn RM, Chen SY, Lee PH, et al. Silencing of glutathione S-transferase P1 by promoter hypermethylation and its relationship to environmental chemical carcinogens in hepatocellular carcinoma. Cancer Lett 2005; 221:135 - 143
   PubMed Web of Science ®Google Scholar
• Agrawal A, Murphy RF, Agrawal DK. DNA methylation in breast and colorectal cancers. Mod Pathol 2007; 20:711 - 721
   PubMed Web of Science ®Google Scholar
• Esteller M, Guo M, Moreno V, Peinado M, Capella G, Galm O, et al. Hypermethylation-associated inactivation of the cellular retinol-binding-protein 1 gene in human cancer. Cancer Res 2002; 62:5902 - 5905
   PubMed Web of Science ®Google Scholar
• Radpour R, Kohler C, Haghighi MM, Fan AX, Holzgreve W, Zhong XY. Methylation profiles of 22 candidate genes in breast cancer using high-throughput MALDI-TOF mass array. Oncogene 2009; 28:2969 - 2978
   PubMed Web of Science ®Google Scholar
• Krassenstein R, Sauter E, Dulaimi E, Battagli C, Ehya H, Klein-Szanto A, et al. Detection of breast cancer in nipple aspirate fluid by CpG island hypermethylation. Clin Cancer Res 2004; 10:28 - 32
   PubMed Web of Science ®Google Scholar
• Kwabi-Addo B, Chung W, Shen L, Ittmann M, Wheeler T, Jelinek J, et al. Age-related DNA methylation changes in normal human prostate tissues. Clin Cancer Res 2007; 13:3796 - 3802
   PubMed Web of Science ®Google Scholar
• Farias E, Ong D, Ghyselinck N, Nakajo S, Kuppumbatti Y, Mira y Lopez R. Cellular retinol-binding protein I, a regulator of breast epithelial retinoic acid receptor activity, cell differentiation and tumorigenicity. J Natl Cancer Inst 2005; 97:21 - 29
   PubMed Web of Science ®Google Scholar
• Kuppumbatti YS, Bleiweiss IJ, Mandeli JP, Waxman S, Mira-Y-Lopez R. Cellular retinol-binding protein expression and breast cancer. J Natl Cancer Inst 2000; 92:475 - 480
   PubMed Web of Science ®Google Scholar
• Arapshian A, Bertran S, Kuppumbatti YS, Nakajo S, Mira-y-Lopez R. Epigenetic CRBP downregulation appears to be an evolutionarily conserved (human and mouse) and oncogene-specific phenomenon in breast cancer. Mol Cancer 2004; 3:13 - 25
   PubMed Web of Science ®Google Scholar
• Veeck J, Niederacher D, An H, Klopocki E, Wiesmann F, Betz B, et al. Aberrant methylation of the wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis. Oncogene 2006; 25:3479 - 3488
   PubMed Web of Science ®Google Scholar
• Donninger H, Vos M, Clark G. The RASSF1A tumor suppressor. J Cell Sci 2007; 120:3163 - 3172
   PubMed Web of Science ®Google Scholar
• Agathanggelou A, Cooper W, Latif F. Role of the ras-association domain family 1 tumor suppressor gene in human cancers. Cancer Res 2005; 65:3497 - 3508
   PubMed Web of Science ®Google Scholar
• Lehmann U, Langer F, Feist H, Glockner S, Hasemeier B, Kreipe H. Quantitative assessment of promoter hypermethylation during breast cancer development. Am J Pathol 2002; 160:605 - 612
   PubMed Web of Science ®Google Scholar
• Shukla S, Mirza S, Sharma G, Parshad R, Gupta S, Ralhan R. Detection of RASSF1A and RARbeta hypermethylation in serum DNA from breast cancer patients. Epigenetics 2006; 1:88 - 93
   PubMed Web of Science ®Google Scholar
• Suijkerbuijk KP, van der Wall E, Vooijs M, van Diest PJ. Molecular analysis of nipple fluid for breast cancer screening. Pathobiology 2008; 75:149 - 152
   PubMed Web of Science ®Google Scholar
• Euhus D, Bu D, Ashfaq R, Xie X, Bian A, Leitch AM, et al. Atypia and DNA methylation in nipple duct lavage in relation to predicted breast cancer risk. Cancer Epidemiol Biomarkers Prev 2007; 16:1812 - 1821
   PubMed Web of Science ®Google Scholar
• Shaw RJ, Liloglou T, Rogers SN, Brown JS, Vaughan ED, Lowe D, et al. Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing. Br J Cancer 2006; 94:561 - 568
   PubMed Web of Science ®Google Scholar
• Keinan-Boker L, Lerner-Geva L, Kaufman B, Meirow D. Pregnancy-associated breast cancer. Is Med Assoc J 2008; 10:722 - 727
   PubMed Web of Science ®Google Scholar
• Raftery A. Bayesian model selection in social research. Sociol Methodol 1995; 25:111 - 163
   Web of Science ®Google Scholar